Skip to main content

sodium zirconium cyclosilicate 5 g/5g Medicare Part D Coverage

Brand name: LOKELMA
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
97%
of Medicare Part D plans
cover sodium zirconium cyclosilicate
5,370 of 5,530 plans
3.2
Avg. formulary tier
$0.00
Median 30-day copay
$0.00–$0.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify sodium zirconium cyclosilicate. Lower tiers = lower copays.

Tier 1 - Preferred Generic 3%
162 plans • avg $0.00/mo
Tier 2 - Generic 0%
12 plans • avg $3.00/mo
Tier 3 - Preferred Brand 75%
4,007 plans • avg $8.23/mo
Tier 4 - Non-Preferred Drug 22%
1,189 plans • avg $4.21/mo

Find the cheapest plan for sodium zirconium cyclosilicate

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for sodium zirconium cyclosilicate →

Get sodium zirconium cyclosilicate Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

sodium zirconium cyclosilicate Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about sodium zirconium cyclosilicate

97% of Medicare Part D plans cover sodium zirconium cyclosilicate. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for sodium zirconium cyclosilicate on Medicare Part D is $0.00 at a preferred pharmacy. Costs range from $0.00 to $0.00 depending on the plan.

sodium zirconium cyclosilicate is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for sodium zirconium cyclosilicate. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →